Treatment with bestatin (the exogenous synthetic inhibitor of metalloproteinases) reduces the activity of metalloproteinase 2 and 12 in the spleen and lung tissues of rats in a model of lipopolysaccharide-induced sepsis.

Autor: Nieradko-Iwanicka, Barbara1 (AUTHOR) barbara.nieradko-iwanicka@umlub.pl, Piasecki, Jarosław2 (AUTHOR), Borzęcki, Andrzej1 (AUTHOR)
Zdroj: Biomedicine & Pharmacotherapy. May2024, Vol. 174, pN.PAG-N.PAG. 1p.
Databáze: Academic Search Ultimate